Physician Photo

Aditya Bardia, MBBS, MPH

  • Phone: 617-724-4000
Department of Medicine


  • Cancer Center
  • Breast Cancer
Clinical Interests
Breast cancer
Targeted therapies
Boston: Massachusetts General Hospital
Medical Education
MBBS, All India Institute of Medical Sciences
MPH, University of Iowa College of Public Health
Residency, All India Institute of Medical Sciences
Residency, Mayo Clinic
Fellowship, The Johns Hopkins Hospital
Board Certifications
Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine
Patient Gateway
Yes, learn more
Foreign Languages
Patient Age Group
Accepting New Patients
Accepting New Patients

BiographyDr. Bardia is a board-certified medical oncologist interested in developing successful targeted and personalized therapies to improve the outcomes of patients and families afflicted with breast cancer. The accurate identification of target is crucial for success of targeted therapies, and Dr. Bardia is involved in the clinical development of tumor genotyping as well as circulating tumor cells (CTCs) to facilitate accurate diagnosis, therapy selection, and real-time monitoring of breast cancer. In collaboration the CTC center and Haber lab, his research on molecular changes in CTCs in metastatic breast cancer has elucidated the role of epithelial-mesenchymal transition, and provided proof-of-principle that ex-vivo CTC culture and molecular drug testing is feasible in breast cancer. Dr. Bardia is the principal investigator of clinical trials investigating the role of targeted therapy combinations for breast cancer. Dr. Bardia is the recipient of Young Investigator Award from the ASCO Conquer Cancer Foundation.


View my most recent publications at PubMed

Selected Publications
  1. Bardia A, Hartmann LC, et al. Leisure time physical activity & risk of postmenopausal breast cancer. Arch Intern Med. 2006;166:2478-83.
  2. Bardia A, Barton DL, et al. Efficacy of complementary & alternative medicine therapies in relieving cancer pain: Systematic Review. J Clin Oncol. 2006;24:5457-64.
  3. Bardia A, Ebbert JO, et al. Association of aspirin & other NSAID use with cancer incidence and mortality among post menopausal women. J Natl Cancer Inst. 2007;99(11):881-9.
  4. Bardia A, Stearns V. Personal Breast. Breast Cancer Res Treat. Editorial. 2010;120(2):437-9.
  5. Bardia A, Stearns V. Personalized Tamoxifen. Clin Cancer Res. Editorial. 2010;16(17):4308-10.

Mass. General study identifies genomic differences between breast cancers of African American and white women

A study from investigators at the MGH Cancer Center has, for the first time, identified genomic differences between the breast tumors of African American and white women, differences that could contribute to the recognized differences in recurrence rate and survival.

55 Fruit Street
Boston, MA 02114-2696

Phone: 617-724-4000
Phone 2: 617-643-0744
Fax: 617-643-0589